Pharmacy

2024 HRS - Cultural Catalyst: Igniting Change Through Collective Empowerment

Healthcare teams lack awareness and knowledge about harm reduction services, including 1) prevention and response efforts, 2) available resources, 3) promising practices, 4) disease testing and...

2024 HRS - Sex Work In Harm Reduction A Kentucky Perspective

Healthcare teams lack awareness and knowledge about harm reduction services, including 1) prevention and response efforts, 2) available resources, 3) promising practices, 4) disease testing and...

2024 HRS - Defining Stimulant Use Disorder Within Harm Reduction Framework

Healthcare teams lack awareness and knowledge about harm reduction services, including 1) prevention and response efforts, 2) available resources, 3) promising practices, 4) disease testing and...

Taking HIV Care to The Streets: How Street Medicine Meets the Unsheltered Homeless Where They're At

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Couture Care: Transcare as A Strategy to HIV Prevention and Treatment

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Strategies for HIV Treatment including Long-Acting ART

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

HIV Diagnostic Perils and Pitfalls: from Pregnancy to PrEP and Beyond

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Update on Management of Hepatitis B & C

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Treating Hepatitis C in Rural Communities Impacted by the Opioid/HCV Syndemic: Results from the KeY Treat Study

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

To Pap or Not to Pap? That and other questions In HIV Primary Care

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Sexually Transmitted Infections: What's New in Treatment and Prevention

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

REPRIEVE Trial – What Does it Mean for Providers and Patients?

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Navigating the Complexity of Anxiety and ADHD symptoms

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Addressing Challenges in Alzheimer’s Disease Among People with HIV

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Sexual Wellness Clinics to Low Barrier to Care Access Centers: Pitfalls and Successes

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Intersection of Immigration & HIV Status

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Updates on Latent Tuberculosis Infection

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

Utilizing Psychedelics to Provide Mental Health Support to Underserved and Vulnerable Populations

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for...

SMART Recovery: SMART Recovery for Concerned Loved Ones & Family and Friends

SMART Recovery tools uses evidence-based methods that have been proven to be more successful than harsh interventions or complete detachment, but if often not recommended by healthcare professionals when...

Q&A SMART Recovery: SMART Recovery for Concerned Loved Ones & Family and Friends

SMART Recovery tools uses evidence-based methods that have been proven to be more successful than harsh interventions or complete detachment, but if often not recommended by healthcare professionals when...

Syringe Services Programs

Syringe Services Programs (SSP’s), also called Syringe Exchange Programs (SEP’s), are a key component of a comprehensive strategy to address the opioid, HIV and Hepatitis C epidemics, providing...

Treatment of OUD in LGBTQ+ Populations

Individuals that identify as LGBTQ+ have unique healthcare needs and treatment considerations. Understanding Minority Stress and how this affects recovery is crucial for the treatment of OUD in the LGBTQ+...

Making Strong Referrals for Opioid Use Disorder Treatment

Individuals with substance use disorders often face barriers to seeking sustainable resources to improve their recovery capital.  Transition between care settings presents vulnerabilities to individuals...

Q&A Making Strong Referrals for Opioid Use Disorder Treatment

Individuals with substance use disorders often face barriers to seeking sustainable resources to improve their recovery capital.  Transition between care settings presents vulnerabilities to individuals...

Overview of Xylazine

Xylazine is a non-opioid used as a sedative for animals and is gaining emergence across the USA.  Xylazine is most often found mixed into opioids like fentanyl to extend the effects. Many individuals...

Q&A Overview of Xylazine

Xylazine is a non-opioid used as a sedative for animals and is gaining emergence across the USA.  Xylazine is most often found mixed into opioids like fentanyl to extend the effects. Many individuals...

Q&A Session for Chronic Pain Management in PWUD

Pain is often misunderstood and not adequately treated by providers. Additionally, studies have shown that there is a provider bias when treating non-white patients for chronic pain.  As a result,...

A Discussion on Boundaries for Peer Support Specialists and Care Navigators

Peer support specialist (PSS) and care navigation services, especially in SUD treatment, is a novel growing field and it is important for these individuals to understand their profession role and...

Q&A A Discussion on Boundaries for Peer Support Specialists and Care Navigators

Peer support specialist (PSS) and care navigation services, especially in SUD treatment, is a novel growing field and it is important for these individuals to understand their profession role and...

Healing the Opioid Crisis with Mindfulness-Oriented Recovery Enhancement: Outcomes and Mechanisms of An Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Addiction

The opioid crisis and chronic pain have been empirically linked to the rising tide of morbidity and mortality (↑ 0.5% a year since 1998) observed among white U.S. adults.  Opioid addiction and...

Q&A Healing the Opioid Crisis with Mindfulness-Oriented Recovery Enhancement: Outcomes and Mechanisms of An Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Addiction

The opioid crisis and chronic pain have been empirically linked to the rising tide of morbidity and mortality (↑ 0.5% a year since 1998) observed among white U.S. adults.  Opioid addiction and...

Q&A for Treatment of OUD in LGBTQ+ Populations

Individuals that identify as LGBTQ+ have unique healthcare needs and treatment considerations. Understanding Minority Stress and how this affects recovery is crucial for the treatment of OUD in the LGBTQ+...

Cancer, Pain, and Opioid Use Disorder

Almost two million Americans are diagnosed with a new cancer and 33% will experience moderate or severe pain.  Patients who are also diagnosed with an Opioid Use...

Q&A Session Cancer, Pain, and Opioid Use Disorder

Almost two million Americans are diagnosed with a new cancer and 33% will experience moderate or severe pain.  Patients who are also diagnosed with an Opioid Use...

CPD 1: LAN MAT: What You Need to Know - An Overview of Long-acting Naltrexone (LAN)

Opioid misuse and addiction is a serious national crisis.

• Affects public health and social and economic welfare.
• Daily, more than 90 Americans die after overdosing on opioids.
...
Faculty

Melanie Dicks, PharmD

CPD 2: Risky Business - Screening Patients for Substance Use Disorder

According to the Substance Use Mental Health Service Administration (SAMHSA) nearly 80% of people with an opiate use disorder do not receive treatment. Because of this more healthcare providers need to screen...

CPD 3: Help Me Find My Way - Referring Patients to Treatment & Resources

According to the Substance Use Mental Health Service Administration (SAMHSA) nearly 80% of people with an opiate use disorder do not receive treatment. More healthcare providers need to screen for substance...

CPD 4: Medications Used to Treat Opiate Use Disorder​

Substance use disorder (OUD) is a treatable, chronic disease that often involves cycles of relapse and remission. Individuals who are under the influence of these substances often engage in risky and...

CPD 5: Powering Recovery - Other Substance Use Disorder Treatments

According to the American Society of Addiction Medicine, addiction is a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and...

CPD 6: Pain & Promise - Pain Management and Patient Contracts

Higher opioid prescribing puts patients at risk for addiction and overdose. According to the CDC (2016) since 1999 more than 165,000 people have died of an overdose related to prescription opioids and as many...

CPD 7: Crosstalk - Communicating and Addressing Patient Challenges

Substance use disorder (SUD) is a treatable, chronic disease that often involves cycles of relapse and remission due to complex interactions in the brain, heredities, and an individual’s environment...

Beacons of Hope: Discussing Naloxone with Patients

Current primary care practice sites are ripe with patients who may need naloxone as a reversal agent to be used in the event of an opioid overdose or emergency. Primary care providers need additional education...

Weighing the Odds: LAN MAT Risks & Benefits

Current primary care practice sites are rarely providing medication-assisted treatment (MAT) as part of the comprehensive care needed for patients who suffer from substance use disorder (SUD) and are seen in...

You Want to Know What?: The Importance of Patient Screening

Opioid misuse and addiction is a serious national crisis that affects public health and social and economic welfare. Daily, more than 90 Americans die after overdosing on opioids.

The treatment of...

Discussing LAN MAT with Provider - Patient Vignette

This is an encounter for a new patient to a primary care practice where all patients are screened for drug and alcohol use. The patient is going to complete a DAST-10 Questionnaire which asks a series of...

How to Use Nalaxone - Patient Vignette

In this vignette, the Pharmacist is meeting with a Patient who is potentially at risk of an opioid overdose. The Patient has been on a short course and has just received another prescription for...

Pharmacy-based initiative in the treatment of Opioid Use Disorder and Harm Reduction

Pharmacy-based care normalizes receipt of medication for opioid use disorder (MOUD), which may increase treatment engagement and reduce stigma and overdose...

Part 2: The Intersection of Criminal Legal system Involvement and Behavioral Health for Treatment

Faculty

Q&A The ADA and Its Implications for Patients with OUD: A Workshop

Patients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA),...

Q&A Session for Alcohol Use Disorder in the Hospitalized Patient

Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD...

Alcohol Use Disorder in the Hospitalized Patient

Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD...

The ADA and Its Implications for Patients with OUD: A Workshop

Patients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA),...

Harm Reduction in the Time of Fentanyl: A Canadian Perspective

Faculty

Opioid and Cannabinoid Interactions: Abuse Potential and Clinical implications

Individuals that use opioids often use cannabinoids Faculty

Rapid Drug Testing and Checking

Faculty

Long-Acting Injectable Buprenorphine

Individuals with OUD need more treatment options that can address...

Part 1: The Intersection of Criminal Legal system Involvement and Behavioral Health

Faculty

Q&A Session: Functional Family Therapy: A Strong Foundation for Practice with Families Who Are Stuck

If you ask most people what is important to them, Faculty

Racial Inequities in Substance Use Treatment

Overdose deaths per 100,000 people occur at a higher rate with the Black/Non-Hispanic and American Indian, Alaska Natives than with White/Non-Hispanic group.  Culturally responsive services are crucial to...